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EXPERIMENTAL STUDY
Effect of Ermiao Fang with Xixin (Herba Asari Mandshurici) on bone
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Abstract
OBJECTIVE: To investigate the effects of Ermiao
Fang (EM) with medical guide Xixin (Herba Asari
Mandshurici) (HAM) on bone marrow stem cell mi-
gration to a focal zone in osteoarthritis (OA) rats.
METHODS: OA rats were induced by arthrectomy
and assigned to sham-operated, model, EM, or EM
plus HAM groups. All rats were injected with recom-
binant human granulocyte colony-stimulating fac-
tor 30 μg·kg-1·d-1 for 7 days and treated with EM or
EM plus HAM at 1.6 or 1.9 g·kg-1·d-1 for 3 or 6
weeks, respectively. Chondrocyte apoptosis and
cartilage matrix components were tested by trans-
ferase-mediated deoxyuridine triphosphate-biotin
nick end labeling assay and special staining. Levels
of interleukin-1 beta (IL-1β) tumor necrosis factor
alpha (TNF-α) nitric oxide (NO), and inducible nitric
oxide synthase (iNOS) in serum were detected by
enzyme-linked immunosorbent assay or radioim-
munoassay. Matrix metalloproteinases (MMPs)-13,
tissue inhibitors of metalloproteinases (TIMPs)-1,
Bromodeoxyuridine (BrdU), cluster of differentia-
tion 34 (CD34), and stromal cell-derived factor 1
(SDF-1) were measured by immunohistochemical
assay.
RESULTS: The EM and EM plus HAM groups had sig-
nificantly less cartilage damage and synovium in-
flammation the model group. Moreover, the EM
and EM plus HAM groups had less chondrocyte
apoptosis and more proteoglycan and collagen
content than the model group. The EM and EM plus
HAM groups had obviously higher MMPs-13 and
TIMPs-1 expression in the cartilage than the model
group. Moreover, the two formula groups had less
release of IL-1β, TNF-α, NO, and iNOS than model
group. Importantly, the expressions of BrdU, CD34,
and SDF-1 in cartilage were significantly higher in
the EM and EM plus HAM-Medtreated rats than
model group. Notably, the EM plus HAM treatment
seemed to have the greatest effects.
CONCLUSION: HAM improves the therapeutic ef-
fects of EM on OA rats by enhancing BMSC direc-
tional homing to the focal zone.
© 2014 JTCM. All rights reserved.
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Homing;ErmiaoFang;Xixin (HerbaAsariMandshurici)
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INTRODUCTION
Osteoarthritis (OA) is a degenerative joint disease char-
acterized by chondrocyte function loss and extracellu-
lar matrix destruction.1 Surgical and pharmaceutical in-
terventions are difficult for restoration of normal carti-
lage function.2 Bone marrow stromal cells (BMSCs)
have chondrocyte differentiated potency3 and are in-
duced with transforming growth factor beta3 (TGF-β
3) to stimulate proteoglycan and collagen type Ⅱ syn-
thesis.4,5 This synthesis appears to be ideal in therapeu-
tic use for cartilage regeneration and is a new field of
study in the application of stem cells. BMSCs can be
summoned by inflammatory irritation of lesions. How-
ever, the effect of BMSC homing to a focal zone is lim-
ited.6 Therefore, devising an agent or method that can
promote BMSC homing to pathologic tissues is impor-
tant.
Ermiao Fang (EM) is a compound prescription com-
posed of Huangbai (Cortex Phellodendri Amurensis) and
Cangzhu (Rhizoma Atractylodis Lanceae) in a specified
ratio.7 EM has been used as treatment for arthralgia
syndrome (Bi syndrome) in Traditional Chinese Medi-
cine since the Ming Dynasty to clear heat and remove
dampness. Today in clinic, EM is also a basic prescrip-
tion for treating OA.8 Moreover, various medical guide
herbs lead to better curative effects. For example, Xixin
(Herba Asari Mandshurici) (HAM), as a medical guide,
is used in the treatment for arthralgia.9 Although me-
dicinal guide has an obvious effect-directing function,
its link to the application of medicinal guide and hom-
ing of BMSCs has been uncharacterized. This study is
designed to employ granulocyte colony-stimulating fac-
tor (G-CSF) to mobilize BMSCs to peripheral blood
and then observe the influence of EM formula plus
HAM, a medical guide, on mobilized BMSC homing
to an osteoarthritic damaged area.
MATERIALS ANDMETHODS
Chemicals and reagents
Matrix metalloproteinase (MMP)-13 antibody
(275628) and tissue inhibitors of metalloproteinase
(TIMP)-1 antibody were purchased from Abcam
(Cambridge, UK). Tunel kit (08c11b), Brdu antibody
(bu330201), CD34 antibody (10cm61), stromal cell
derived factor (SDF) -1 antibody (Y-07c29c), and type
II collagen antibody (10 cm222) were purchased from
Boster (Wuhan, China). All other chemicals were of
analytical grade.
Herbal preparation
EM was prepared as described in the Chinese Pharma-
copeia of 2010.7 Briefly, the three ingredients, Cang-
zhu (Rhizoma Atractylodis Lanceae) (500 g, fried with
salt) and Huangbai (Cortex Phellodendri Amurensis)
500 g, and Xixin (Herba Asari Mandshurici) (HAM,
200 g) were pulverized to fine powder, suspended in
distilled water to a concentration of 0.16 g/mL (EM)
and 0.19 g/mL (EM + HAM), respectively, and mixed
well before administration.
OA animal model and treatment
Forty-eight male Sprague-Dawley rats of clean grade,
4-months-old, weighing (200-220) g, were purchased
from Experimental Animal Center of Academy Of Mil-
itary Medical Sciences (Certificate No. SCXK [jun]
2007-004) and were anesthetized with halothane. After
being shaved and disinfected, the right knee joint was
exposed with a medial par patellar approach. The patel-
la was dislocated laterally and the knee placed in full
flexion, followed by anterior cruciate ligament transec-
tion and medial meniscus resection (ACLT + MMx)
with micro-scissors. Sham-arthrotomized animals were
negative controls. The rats were randomly divided into
four groups with a random number table method:
ACLT+MMx without treatment (Model, n=12), sham
operated (Sham, n=12), ACLT+MMx rats treated with
EM intragastrically at a daily dose of 1.6 g/kg (EM, n=
12), and treated with EM (1.6 g/kg) plus HAM (0.3 g/
kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (EM
plus HAM, n=12). Dose calculations followed guide-
lines correlating dose equivalents between humans and
laboratory animals, on the basis of ratios of body sur-
face area.10 The dose equivalents 1.6 or 1.9 g/kg are
based on recommended doses of 0.25 or 0.3 g/kg in
humans, respectively. Untreated control rats induced
by ACLT+MMx and sham rats received distilled water
only. Meanwhile, all animals were subcutaneously in-
jected with recombinant human G-CSF (rhG-CSF) at
a dose of 30 μg·kg-1·d-1 for 7 days after arthrectomy.
To label BMSCs, all rats were intraperitoneally inject-
ed with BrdU (50 mg/kg) for 3 days before sampling
at the end of the 3rd and 6th week. All procedures for
consideration of animal welfare were reviewed and ap-
proved by the ethical committee of China Academy of
Traditional Chinese Medicine.
Count of peripheral white blood cells
Before (0 day) and 3, 5, and 7 days after rhG-CSF in-
jection, 20 μL of blood were taken from the orbital ve-
nous plexus. White blood cells (WBC) in peripheral
blood were tested by an automatic biochemical analyz-
er (Hitachi Ltd., Tokyo, Japan).
Histological analysis
Animals were sacrificed after 3 or 6 weeks of treat-
ment, the tibia and femur were dissected, fixed in 4%
paraformaldehyde for 24 h, decalcified in 10% ethyl-
ene diamine tetraacetic acid-2Na for decalcification,
and embedded in paraffin. Tissue sections (4 μm) were
mounted on common slides for staining with hematox-
ylin and eosin (HE), toluidine blue, and Masson's tri-
chrome, as described.11,12 Cartilage histopathological
features were analyzed using the scoring system by
Mankin et al 13 (score ranging from 0-12 for normal to
complete disorganization and hypocellularity). Synovi-
um histopathology was evaluated according to Yoshi-
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mi's histological grading (score ranging 0-18 for nor-
mal to most severe reaction).14 Image-Pro Plus 6.0 Sys-
tem (Media Cybernetics Inc., Rockville, MD, USA)
image analysis system was used for quantitative analy-
sis. The positive index was calculated as integrated opti-
cal density (IOD). All sections were randomized and
evaluated by a trained observer who was blinded to the
treatment groups.
Terminal deoxynucleotide transferase-mediated
dUTP nick-end labeling (TUNEL) staining
Apoptotic cells in specimens were recognized using in
situ cell apoptosis detection kits (Boster) according to
the manufacturer's instructions.15 Briefly, deparaf-
finized sections were permeabilized in 0.1% Triton
X-100, incubated in fluorescein-labeled dUTP and ter-
minal deoxynucleotidyl transferase (TdT) mixture,
then probed using anti-fluorescein antibody conjugat-
ed with alkaline phosphatase. Sections were developed
using a substrate solution containing fast red. Sections
without primary TdT were used as negative controls
for the TUNEL staining. TUNEL-positive cells in
three different areas were counted under a microscope.
Image-Pro Plus 6.0 System (Media Cybernetics Inc.,
Rockville, MD, USA) image analysis system was used
for quantitative analysis.
Immunoblotting analysis
Paraffin sections (4 μm) of joint tissues were mounted
on poly-L-lysine-coated slides. Paraffin sections were
routinely dewaxed and incubated for 10 min with 3%
H2O2. Each section was incubated with blocking serum
(Vectastain ABC Kit, Vector Laboratories, Burlin-
game, CA, USA) at room temperature for 30 min and
then with primary rabbit monoclonal antibody against
type Ⅱ collagen (dilution 1∶30), rabbit polyclonal an-
tibody against MMP-13 (dilution 1∶50), rabbit mono-
clonal antibody against TIMP-1 (dilution 1∶ 80),
mouse monoclonal antibody against Brdu (dilution 1∶
100), rabbit polyclonal antibody against CD34 (dilu-
tion 1∶100), and rabbit polyclonal antibody against
SDF-1 (dilution 1∶50) overnight at 4℃. Sections incu-
bated in phosphate-buffer saline (PBS) without anti-
body served as negative controls. Then, slides were in-
cubated with biotinylated secondary antibody and then
incubated with avidin-biotin complex reagent contain-
ing horseradish peroxidase for 30 min. Sections were
then stained with 3,3'-diaminobenzidine (DAB) (Sig-
ma, St. Louis, MO, USA). Image-Pro Plus 6.0 System
(Media Cybernetics Inc., Rockville, MD, USA) image
analysis system was used for quantitative analysis.
Serum and analysis
Animal blood was collected from the abdominal aorta
and levels of serum interleukin-1β (IL-1β), tumor ne-
crosis factor-α (TNF-α), bone morphogenetic pro-
tein-2 (BMP-2), transforming growth factor beta 1
(TGF-β1) and inducible nitric oxide synthase (iNOS)
were analyzed by enzyme-linked immunosorbent assay
or radioimmunoassay assay. Nitric oxide (NO) was de-
tected by assay kit (Beijing 4A Biotech Co., Ltd., Bei-
jing, China).
Statistics analysis
All data are expressed as mean±standard deviation and
were calculated using a two tailed student's t-test,
two-sample assuming unequal variance, within the Mi-
crosoft Excel 2007 software package from Microsoft
(Redmond, WA, USA) Values were considered signifi-
cantly different if P<0.05.
RESULTS
Mobilization of BMSCs
After rhG-GSF injection, WBC count in peripheral
blood increased, and WBC count increased until reach-
ing its peak on the 7th day. However, there were no
significant differences among the four groups (all P>
0.05) (Figure 1). This suggested that the application of
Figure 1 Comparison ofWBC count among groups before and after rhG-CSF Injection
Model group: ACLT+MMx without treatment (n=12); sham group: sham operated (n=12); EM group: ACLT+MMx rats treated with
EM intragastrically at a daily dose of 1.6 g/kg (n=12); EM plus HAM group: ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM
(0.3 g/kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (n=12). WBC: white blood cells; rhG-CSF: recombinant human granulocyte
colony-stimulating factor; EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate ligament transec-
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rhG-CSF was effective in mobilizing BMSCs to periph-
eral blood.
Pathologic changes of articular cartilage and
synovium
Figure 2 shows in the sham group, HE staining
showed a smooth surface of the articular cartilage with
normal cellularity. In contrast, ACLT+MMx rats had
significant histopathological changes with a significant-
ly increased overall Mankin score compared with sham
rats (P<0.01), as indicated by surface irregularity, disor-
ganization of articular cartilage with apparent cloning
of chondrocytes in the transitional and radial zones,
and disrupted tidemark. These histomorphological
changes in the cartilage were reduced in the EM and
EM plus HAM- Medtreated rats. Meanwhile, the over-
all Mankin scores of the two Traditional Chinese Med-
icine groups were significantly lowered as compared
with those of the model group at 3 and 6 weeks treat-
ment (P<0.01 or P<0.05). Notably, EM plus HAM
significantly lowered the overall Mankin scores com-
pared with EM at 6 weeks (P<0.05).
Untreated ACLT+MMx rats had more hyperplasia of
synovial lining cells, hypertrophy of synovial lining lay-
er, and growth of the infiltration of inflammatory cells
in synovial tissue compared with sham rats. EM and
EM plus HAM rats had less hypertrophy of the synovi-
al lining layer, inflammatory cellular infiltration, and
had significantly lower histological severity scores com-
pared with untreated ACLT+MMx rats after 6 weeks
of treatment (P<0.05 or 0.01). The largest inflamma-
tion suppression was found in the EM plus HAM
HG




Figure 2 Comparison of effects on cartilage histology and Mankin's score
A-H: histopathologic changes of cartilage in weeks 3 and 6 (HE staining ×200). A-D: histopathologic changes of Sham, Model, EM
and EM plus HAM in week 3; E-H: histopathologic changes of Sham, Model, EM and EM plus HAM in week 6. I-L: the Makin's score
of cartilage, the scores of structure, cell and tidemark in weeks 3 and 6. Model group: ACLT+MMx without treatment (n=12); sham
group: sham operated (n=12); EM group: ACLT+MMx rats treated with EM intragastrically at a daily dose of 1.6 g/kg (n=12); EM
plus HAM group: ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM (0.3 g/kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (n=
12). HE: hematoxylin and eosin; EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate ligament
transection and medial meniscus resection. aP<0.01, compared with the sham group. bP<0.01 and cP<0.05, compared with the
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group. However, there were no significant differences
between the EM and EM plus HAM groups. (Figure 3)
Chondrocyte apoptosis
Figure 4 shows that there were many apoptotic chon-
drocytes in the cartilage of untreated ACLT+MMx rats
in weeks 3 or 6. EM and EM plus HAM rats had sig-
nificantly lower percentages of apoptotic chondrocytes
in weeks 3 or 6. The EM plus HAM group had 35%
fewer apoptotic chondrocytes compared with EM treat-
ment in week 6 (P<0.01).
Cartilage matrix repair
Untreated ACLT+MMx rats had significantly less pro-
teoglycan, collagen, and type Ⅱ collagen in weeks 3 or
6. The EM and EM plus HAM groups had significant-
ly higher levels of proteoglycan and collagen and more
expression of type Ⅱ collagen in week 6 compared
with the model group. EM plus HAM group had a
1.2-, 1.3- and 1.3-fold increase in respective proteogly-
can, collagen and type Ⅱ collagen expressions, com-
pared with the EM treatment group in week 6 (all P<
0.05) (Figure 5).
Expressions of MMP-13 and TIMP-1 in articular
cartilage
Figure 6 shows that ACLT + MMx induced a signifi-
cant increase in MMP-13 expressions and a clear de-
crease of TIMP-1 expressions in the joints in weeks 3
or 6. EM and EM plus HAM treatment showed signifi-
cant differences after 6 weeks of treatment. EM plus
HAM had 15.9% less positive MMP-13 expression
and 26.9% more TIMP-1 expression compared with
the EM group in week 6 (all P<0.05). MMP-13 and
TIMP-1 were expressed in the chondrocytes of the
knee joint in all groups. The positive staining was pre-
dominantly cytoplasmic or cytosolic in the chondro-
cytes.
Expressions of BrdU, CD34, and SDF-1 on
chondrocyte in articular cartilage
Compared with the sham-operated group, the number
of BrdU-positive cells in the model group was higher
both in weeks 3 and 6, but there were no statistical dif-
ferences (P>0.05). Compared with the untreated
HG
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Figure 3 Comparison of effects on synovial histology and Mankin's
score
A-D: synovium histopathologic changes of Sham, Model, EM and
EM plus HAM in week 3 (HE staining, ×200); E-H: the synovium histo-
pathologic changes of Sham, Model, EM and EM plus HAM in week
6 (HE staining, ×200). I-K: the total Makin's score of synovium, the
scores of synovial lining layerand subsynovial tissue in weeks 3 and
6. Model group: ACLT+MMx without treatment (n=12); sham group:
sham operated (n=12); EM group: ACLT+MMx rats treated with EM
intragastrically at a daily dose of 1.6 g/kg (n=12); EM plus HAM
group: ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM (0.3 g/
kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (n=12). HE: hematoxy-
lin and eosin; EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshuri-
ci); ACLT+MMx: anterior cruciate ligament transection and medial
meniscus resection. aP<0.01, compared with the sham group. bP<
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group, in week 3, there were significantly more posi-
tive cells in the EM plus HAM group (P<0.05). How-
ever, in the 6th week, there were significantly more
positive cells in both the formulae groups, while the
most cells were found in the EM plus HAM group.
There was a significant difference between the EM and
EM plus HAM groups (P<0.05) (Figure 7).
The number of CD34 and SDF-1-positive cells in the
untreated group was significantly higher in week 3 and
lower in week 6 as compared with that in the sham-op-
erated group. EM plus HAM group had significantly
greater expressions of CD34 and SDF-1 both in weeks
3 and 6 as compared with the untreated group. Only
in week 6 was the CD34 and SDF-1 expression in the
EM plus HAM group significantly higher than that in
the EM group (P<0.05) (Figure 7).
Serum IL-1β, TNF-α, NO, iNOS, BMP, and
TGF-β1
Serum levels of IL-1β, TNF-α, NO, and iNOS were
significantly higher, and the levels of BMP-2 and
TGF-β1 were significantly lower in the untreated
ACLT + MMx group compared with the sham group.
EM and EM plus HAM groups had significantly lower
levels of IL-1β, TNF-α, NO, iNOS in week 6. Com-
pared with the untreated group, the levels of BMP-2
and TGF-β1 in the EM plus HAM group were signifi-
cantly higher (P<0.05) in week 6. However, there were
no significant differences in the above indexes between
the EM and EM plus HAM groups (Figure 8).
DISCUSSION
BMSC therapy has been used in bone and cartilage re-
pair for osteoarthritis treatment.16 However, the limit-
ed ability of BMSCs to home and repair is the bottle-
neck for BMSC therapy.17,18 Therefore, finding agents
or methods that could promote BMSC homing to le-
sions is popular in OA treatment research. In the pres-
ent study, we evaluated the anti-osteoarthritis effects of
EM and EM plus HAM on the mobilization of BMSC
homing to a focal zone using an ACLT+MMx rat mod-
el. We found significantly less articular cartilage dam-
age and synovium inflammation in the EM and EM
plus HAM groups than in the model group, and HAM
was able to enhance the curative effects of EM on OA.
Moreover, EM plus the medical guide HAM can pro-
mote directional homing of BMSCs to pathologically
damaged areas.
Chondrocyte apoptosis alters the cartilage matrix
(ECM) synthesis, leading to matrix degeneration and
finally to OA.19 Cartilage ECM molecules such as typeⅡ collagen and sulfated proteoglycan play a crucial
role in regulating chondrocyte functions by facilitating
cell-matrix interactions.20 The development and pro-
gression of OA is believed to involve inflammation,
and IL-1β, TNF-α, and NO have been reported to in-
duce apoptosis in chondrocytes and cause extracellular
matrix degration.21 MMP-13 can degrade type Ⅱ colla-
gen and its activities are inhibited by TIMP-1. An im-
balance in the ratio of TIMPs to MMPs causes contin-
ued matrix destruction in OA.22 Our results demon-
Figure 4 Comparison of effects on chondrocytes apoptosis in
weeks 3 and 6
A-H: terminal deoxynucleotide transferase-mediated dUTP nick-
end labeling staining (×200). A-D: the chondrocytes apoptosis of
Sham, Model, EM and EM plus HAM in week 3; E-H: The chondro-
cytes apoptosis of Sham, Model, EM and EM plus HAM at the 6
week. I: Apoptosis index of osteoarthritis chondrocytes. Model
group: ACLT+MMx without treatment (n=12); sham group: sham
operated (n=12); EM group: ACLT+MMx rats treated with EM intra-
gastrically at a daily dose of 1.6 g/kg (n=12); EM plus HAM group:
ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM (0.3 g/kg) at a
daily dose of 1.9 g/kg for 3 or 6 weeks (n=12). EM: Ermiao Fang;
HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate
ligament transection and medial meniscus resection. aP<0.01, com-
pared with the sham group. bP<0.05 and cP<0.01, compared with
the model group. dP<0.01, compared with the EM group.
HG
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strated that EM and EM plus HAM treatment had sig-
nificantly less articular cartilage damage and synovium
inflammation in OA rats in week 6 than that in the
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PG, COL, and COLⅡ were toluidine blue staining, Masson's trichrome staining, and immunohistochemistry, respectively (×200).
I-K: Levels of PG, COL, and COLⅡ. Model group: ACLT+MMx without treatment (n=12); sham group: sham operated (n=12); EM
group: ACLT+MMx rats treated with EM intragastrically at a daily dose of 1.6 g/kg (n=12); EM plus HAM group: ACLT+MMx rats
treated with EM (1.6 g/kg) plus HAM (0.3 g/kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (n=12). PG: proteoglycan; COL: collagen;
COLⅡ: typeⅡ collagen. EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate ligament transec-
tion and medial meniscus resection. aP<0.01, compared with the sham group. bP<0.05 and cP<0.01, compared with the model
group. dP<0.05, compared with the EM group.
Figure 5 Comparison of effects on PG, COL, and COLⅡ
A1-D1: the PG of Sham, Model, EM and EM plus HAM in week 3 ;
E1-H1: the PG of Sham, Model, EM and EM plus HAM in week 6 .
A2-D2: the COL of Sham, Model, EM and EM plus HAM in week 3 ;
E2-H2: the COL of Sham, Model, EM and EM plus HAM in week 6 .
A3-D3: the COLⅡ of Sham, Model, EM and EM plus HAM in week
3; E3-H3: the COLⅡ of Sham, Model, EM and EM plus HAM in week
6. Dyeing methods of PG, COL, in week 6. A3-D3: the COL Ⅱ of
Sham, Model, EM and EM plus HAM in week 3; E3-H3: the COL Ⅱ
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had less chondrocyte apoptosis and more proteoglycan
and collagen content, particularly type Ⅱ collagen ex-
pression. Both formulae obviously interfered with
OA-augmented expressions of MMPs-13 and EM plus
HAM clearly augmented OA-reduced TIMPs-1 expres-
sion in the knee joints. Moreover, the two formulae
groups had significantly less release of IL-1β, TNF-α,
NO, and iNOS in serum and the EM plus HAM
group had significantly higher BMP-2 and TGF-β1
levels. Importantly, the expressions of BrdU, CD34,
and SDF-1 in articular cartilage were significantly high-
er than those in the model group. The largest changes
in these parameters were found in the EM plus HAM
group. Articular cartilage repair of EM plus HAM is
better than EM in ACLT+MMx rats. Because BMSCs
have chondrocyte and ECM differentiation potential,
our results suggest that the activity of EM plus HAM
may be related to BMSC repair therapy.
BrdU is an analogue of thymidine, which is able to in-
corporate into the nucleus of cells during proliferation
or division.23 Therefore, it is widely used to label stem
cells. After an intraperitoneal injection with BrdU, an
increasing trend of BrdU-positive expression was de-
tected in weeks 3 and 6 in the ACLT + MMx model.
This suggested that, after damage of competent cells
(such as osteocytes, chondrocytes, and bone marrow
cells), a self-repair mechanism was initiated, and then
the activated stem cells joined in the repairing activity
of the articular cartilage. Although the BrdU-positive
expression of the model group was higher than that of
the sham-operated group, the homing stem cells were
inadequate for sufficient repair, and the histopathology
featured articular cartilage damage. After treatment
with the two formulae, there were more BrdU positive
cells. In week 3, the positive cell count of the EM plus
JI
H2G2
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Figure 6 Comparison of expressions of MMP-13 and TIMP-1 in the knee joints (×200)
A1-D1: the MMP-13 of Sham, Model, EM and EM plus HAM in week 3; E1-H1: the MMP-13 of Sham, Model, EM and EM plus HAM
in week 6. A2-D2: the TIMP-1 of Sham, Model, EM and EM plus HAM in week 3; E2-H2: the TIMP-1 of Sham, Model, EM and EM plus
HAM in week 6. Immunohistochemistry was used in all frames. I and J: IOD of MMP-13 and TIMP-1. Model group: ACLT+MMx with-
out treatment (n=12); sham group: sham operated (n=12); EM group: ACLT+MMx rats treated with EM intragastrically at a daily
dose of 1.6 g/kg (n=12); EM plus HAM group: ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM (0.3 g/kg) at a daily dose of 1.9
g/kg for 3 or 6 weeks (n=12). MMP-13: matrix metalloproteinases-13; TIMP-1: tissue inhibitors of metalloproteinases-1; IOD: inte-
grated optical density; EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate ligament transection
and medial meniscus resection. aP<0.01, compared with the sham group. bP<0.05 and cP<0.01, compared with the model group.
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HAM group exceeded that of the model group, while
the EM and model groups were not significantly differ-
ent. The stem cells could possibly differentiate into
chondrocytes or extracellular matrix, and there was sig-
plus HAM (0.3 g/kg) at a daily dose of 1.9 g/kg for 3 or 6 weeks (n=12). BrdU: bromodeoxyuridine; CD34: cluster of differentiation
34; SDF-1: stromal cell derived factor 1; IOD: integrated optical density; EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici);
ACLT+MMx: anterior cruciate ligament transection and medial meniscus resection. aP<0.05 and bP<0.01, compared with the mod-
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Figure 7 Comparison of expressions of Brdu, CD34, and SDF-1 in
the knee joints (×200)
A1-D1: the Brdu of Sham, Model, EM and EM plus HAM in week 3;
E1-H1: the Brdu of Sham, Model, EM and EM plus HAM in week 6.
A2-D2: the CD34 of Sham, Model, EM and EM plus HAM in week 3;
E2-H2: the CD34 of Sham, Model, EM and EM plus HAM in week 6.
A3-D3: the SDF-1 of Sham, Model, EM and EM plus HAM in week 3 ;
E3-H3: the SDF-1 of Sham, Model , EM and EM plus HAM in week 6.
Immunohistochemistry was used in all frames (×200). I-K: IOD of Br-
du, CD34, and SDF-1. Model group: ACLT+MMx without treatment
(n=12); sham group: sham operated (n=12); EM group: ACLT+MMx
rats treated with EM intragastrically at a daily dose of 1.6 g/kg (n=
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nificantly more repair observed in the articular carti-
lage of both formulae groups. In addition, the articular
cartilage Mankin score of the EM plus HAM group
was markedly lower than that of the EM group. This
indicated that HAM could further promote stem cell
homing and the initiation of homing was relatively
earlier.
The CD34 molecule is a transmembrane salivary mu-
cin, and is considered to be a positive sign of hemato-
poietic stem cells.24 In this study, we found that the
CD34 expression in week 6 was lower than that in
week 3. The reason was possibly because the differenti-
ation of activated stem cells occurred in week 6. EM is
able to slightly up-regulate the positive expression of
CD34, and this effect was enhanced after addition of
HAM. This difference was clearly observed in terms of
CD34 level in week 6, which is consistent with the sig-
nificantly higher BrdU-positive cell count at the same
time. These results suggested that HAM might pro-
mote BMSC homing to the damage area.
SDF-1 is the first reported chemoattractant protein
that participates in the homing course of stem and pro-
Figure 8 Comparison of effects on IL-1β, TNF-α, NO, iNOS, BMP-2, and TGF-β1 in serum
A-F: the levels of IL-1β, TNF-α, NO, iNOS, BMP-2, and TGF-β1 in serum in weeks 3 and 6. Model group: ACLT+MMx without treatment
(n=12); shamgroup: shamoperated (n=12); EMgroup: ACLT+MMx rats treatedwith EM intragastrically at a daily dose of 1.6 g/kg (n=
12); EM plus HAM group: ACLT+MMx rats treated with EM (1.6 g/kg) plus HAM (0.3 g/kg) at a daily dose of 1.9 g/kg for 3 or 6
weeks (n=12). EM: Ermiao Fang; HAM: Xixin (Herba Asari Mandshurici); ACLT+MMx: anterior cruciate ligament transection and me-
dial meniscus resection. Data represent the mean±SD of samples with 6 rats in each. aP<0.05, bP<0.01 compared with the sham
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genitor cells. Furthermore, the homing of stem cells is
dependent on the SDF-1 concentration gradient.25 In
this study, EM was able to significantly up-regulate the
positive expression of SDF-1 and thereby facilitate BM-
SC homing activity. This effect was significantly en-
hanced after addition of HAM in week 6, which is con-
sistent with the significantly higher BrdU-positive cell
count at the same time. Therefore, HAM might pro-
mote BMSC homing to damage by increasing SDF-1
levels in pathologic tissues and consequently boosting
the repair activity.
In conclusion, EM and EM plus HAM exert signifi-
cant anti-osteoarthritis effects in ACLT+MMx rats. Im-
portantly, by studying the influence of EMR plus
HAM (a medicinal guide) on BMSCs homing to dam-
age focus and repair function, we primarily expound
the mechanism of HAM in enhancing curative effects
of EM for OA may be by promoting the homing of
BMSCs of peripheral blood to the damage focus. The
facilitation of BMSC homing to pathologic areas could
be the biological manifestation of HAM guiding other
drugs to a focal zone.
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